Old Web
English
Sign In
Acemap
>
authorDetail
>
Bosse Jessen
Bosse Jessen
Humboldt University of Berlin
Infliximab
Inflammatory bowel disease
Medicine
Tumor necrosis factor alpha
Ulcerative colitis
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identifizierung prädikativer Parameter für ein Therapieansprechen auf anti-TNFα-Antikörper bei Patient*innen mit chronisch entzündlichen Darmerkrankungen
2021
Bosse Jessen
Show All
Source
Cite
Save
Citations (0)
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.
2020
Clinical Gastroenterology and Hepatology
Bosse Jessen
Yasmina Rodriguez Sillke
Elena Sonnenberg
Michael Schumann
A. A. Kruglov
Inka Freise
Franziska Schmidt
Jochen Maul
Anja A. Kühl
Rainer Glauben
Donata Lissner
Britta Siegmund
Show All
Source
Cite
Save
Citations (5)
1
map